These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7300920)

  • 1. Central effects of paraoxon on haemodynamics in the cat.
    de Neef JH; Porsius AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):168-72. PubMed ID: 7300920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressor effects, drug concentration and cholinesterase activities in the brain after administration of paraoxon in the cat.
    De Neef JH; Van Rooy HH; Porsius AJ
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):15-27. PubMed ID: 6625764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central cardiovascular effects of physostigmine in the cat; possible cholinergic aspects of blood pressure regulation.
    de Wildt DJ; Porsius AJ
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):22-39. PubMed ID: 6119963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of paraoxon on blood pressure in the anaesthetized and in the conscious rat.
    De Neef JH; Jordaan KM; Porsius AJ
    Br J Pharmacol; 1982 Oct; 77(2):223-32. PubMed ID: 7139183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The central effects of paraoxon on blood pressure of rabbits after intravenous administration or infusion via a vertebral artery.
    de Neef JH; Manneke A; Porsius AJ
    Arch Toxicol; 1982 Sep; 50(3-4):241-7. PubMed ID: 7149989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of physostigmine on sympathetic outflow and haemodynamics by an action upon the pontomedullary region of the cat.
    de Wildt DJ; Porsius AJ
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):40-51. PubMed ID: 7325755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of efferent sympathetic nerve activity by centrally administered paraoxon in the cat.
    De Neef JH; Borgdorff P; Porsius AJ
    Eur J Pharmacol; 1982 Jun; 81(1):123-7. PubMed ID: 7117365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrally induced cardiovascular effects and kinetic behaviour of isoarecaidine propyl ester in the cat.
    Porsius AJ; Lambrecht G; Moser U; Mutschler E
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):22-35. PubMed ID: 7092417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pressor effects of paraoxon in the pithed rat.
    De Neef JH; Porsius AJ
    Br J Pharmacol; 1982 Oct; 77(2):233-8. PubMed ID: 7139184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central actions of nicotine on blood pressure and heart rate after administration via the left vertebral artery of anaesthetized cats. Distribution of nicotine into the brain after central application.
    Porsius AJ; Van Zwieten PA
    Arzneimittelforschung; 1978; 28(9):1628-31. PubMed ID: 582567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressor effects of the alpha 2-adrenoceptor agonist B-HT 933 in anaesthetized and haemorrhagic rats: comparison with the haemodynamic effects of amidephrine.
    MacLean MR; Thomson M; Hiley CR
    Br J Pharmacol; 1989 Jun; 97(2):419-32. PubMed ID: 2569342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The simultaneous infusion of drugs via the left and right vertebral artery of the cat; a modified animal model for the study of possible central actions of drugs upon the lower brain stem.
    Porsius AJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):260-71. PubMed ID: 7224708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and respiratory responses evoked from the posterior cerebellar cortex and fastigial nucleus in the cat.
    Bradley DJ; Pascoe JP; Paton JF; Spyer KM
    J Physiol; 1987 Dec; 393():107-21. PubMed ID: 3446792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular action of detomidine, a sedative and analgesic imidazole derivative with alpha-agonistic properties.
    Savola JM; Ruskoaho H; Puurunen J; Kärki NT
    Eur J Pharmacol; 1985 Nov; 118(1-2):69-76. PubMed ID: 2867913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central hypotensive and antihypertensive activities of imidazolidines, structurally related to clonidine.
    Timmermans PB; Van Zwieten PA
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):251-67. PubMed ID: 921415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the central nervous system in the cardiovascular responses to yohimbine.
    Lang WJ; Lambert GA; Rush ML
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):57-67. PubMed ID: 242288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic changes and acetylcholine-induced hypotensive responses after NG-nitro-L-arginine methyl ester in rats and cats.
    Marcel van Gelderen E; Heiligers JP; Saxena PR
    Br J Pharmacol; 1991 Aug; 103(4):1899-904. PubMed ID: 1912978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
    Sassen LM; Soei LK; Koning MM; Verdouw PD
    Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central hypotensive activity of ketanserin in cats.
    van Zwieten PA; Mathy MJ; Boddeke HW; Doods HN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S54-8. PubMed ID: 2446072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central respiratory depression induced by acetylcholinesterase inhibition: involvement of anaesthesia.
    Foutz AS; Boudinot E; Denavit-Saubié M
    Eur J Pharmacol; 1987 Oct; 142(2):207-13. PubMed ID: 3691638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.